Business
– – 2013 was a positive year for Israeli high-tech and biotech, in almost every respect: total investments rose, salaries rose, and there were...
Hi, what are you looking for?
– – 2013 was a positive year for Israeli high-tech and biotech, in almost every respect: total investments rose, salaries rose, and there were...
– RedHill Biopharma Ltd. (Nasdaq: RDHL; TASE: RDHL), today announced that it has entered into a definitive agreement with leading healthcare investor OrbiMed Israel Partners...
– Borderfree and Outbrain are expected to hold IPOs on Wall Street, while Matomy is heading for London. – / By Shmulik Shelach, Roy Goldenberg...
– – Security researchers at Ben Gurion University (BGU), have identified a critical vulnerability in highly secure Samsung mobile devices which are...
– The company also raised NIS 63 million in future options and hopes to bring two products to the European market by 2015. –...
– The Adverse Event Profile for Rolapitant was Consistent with Earlier Clinical Trials. Preparations Continue in Support of Submission of a New Drug Application...
– – /By Johanna Weiß/ “Break a leg” may be what people say when they want to wish someone luck, but breaking a leg is...
– Blumenthal , cofounder of the online spectacle portal has seen his company’s total funding level rise to more than $110 million since 2010....
– The 12-week Phase IIb study involving 79 patients with active rheumatoid arthritis met all its primary efficacy endpoints. – Can-Fite BioPharma Ltd. (TASE:CFBI; Bulletin...
– Facebook Joins S&P 500 Facebook has been in the news quite a bit this week. First, Standard & Poor‘s (S&P), a division...